Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
1.
Int. j. cardiovasc. sci. (Impr.) ; 34(1): 81-88, Jan.-Feb. 2021. tab, graf
Article de Anglais | LILACS | ID: biblio-1154539

RÉSUMÉ

Abstract Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome, which accounts for about 50% of patients with heart failure (HF). The morbidity and mortality associated with HFpEF is similar to HFrEF. Clinical trials to date have failed to show a benefit of medical therapy for HFpEF, which may due to lack of uniform phenotypes and heterogeneous population. In addition, medical therapy proven for HFrEF may not address the pathophysiologic basis for HFpEF. Left atrial remodeling and dysfunction is central to HFpEF and accounts for secondary pulmonary hypertension and pulmonary vascular congestion that frequently occurs with exertion. Interatrial shunts represent a novel treatment modality for HFpEF. These shunts allow for left atrial decongestion and a reduction in pulmonary venous hypertension during exercise leading to improvements in hemodynamics, functional status and quality of life. Trials to date have demonstrated safety and short-term efficacy of these devices for HFpEF. The long-term benefits are currently being evaluated in ongoing trials. If effective, the use of interatrial shunts may be a new therapeutic paradigm for the treatment of HFpEF.


Sujet(s)
Défaillance cardiaque diastolique/chirurgie , Remplacement valvulaire aortique par cathéter , Équipement et fournitures , Défaillance cardiaque diastolique/diagnostic , Défaillance cardiaque diastolique/physiopathologie , Défaillance cardiaque diastolique/mortalité , Remodelage auriculaire
2.
Int. j. cardiovasc. sci. (Impr.) ; 33(6): 666-672, Nov.-Dec. 2020. tab, graf
Article de Anglais | LILACS | ID: biblio-1143118

RÉSUMÉ

Abstract Background: Primary care physicians have difficulty dealing with patients who have HF with preserved LVEF(HFpEF). The prognosis of HFpEF is poor, and difficult to predict on primary care. Objective: The aim of the study is to apply the H2FPEF score to primary care patients and verify its power to assess the risk of death or hospitalization due to cardiovascular disease. Methods: This longitudinal study included 402 individuals, with signs or symptoms of HF, aged≥45 years and, underwent an evaluation which included clinical examination, BNP and echocardiogram. The diagnosis of HFpEF was confirmed by the criteria of the European Society of Cardiology. After five years, the patients were reassessed as to the occurrence of the composite outcome, death from any cause or hospitalization for cardiovascular disease. H2FPEF used six variables: body mass index, medications for hypertension, age, pulmonary artery systolic pressure, atrial fibrillation and E/e' ratio ranged from 0 to 9 points. The level of statistical significance was p<0.05. Results: HFpEF was diagnosed in 58(14.4%). Among patients with H2FPEF≥4, 30% had HFpEF and in those with a score≤4, HFpEF was present in 12%. Patients with HFpEF and H2FPEF≥4 had 53% of outcomes, whereas patients with HFpEF and a score ≤4 had a 21% of outcomes. BNP values were higher in patients with HFpEF compared to those without HFpEF(p<0.0001). Conclusion: H2FPEF≥4 indicated a worse prognosis in patients with HFpEF assisted in primary care. H2FPEF may be a simple and useful tool for risk stratification in patients with HFpEF at the primary care.


Sujet(s)
Humains , Mâle , Femelle , Adulte d'âge moyen , Sujet âgé , Soins de santé primaires , Défaillance cardiaque diastolique/diagnostic , Pronostic , Études longitudinales , Appréciation des risques , Défaillance cardiaque diastolique/complications , Défaillance cardiaque diastolique/mortalité
4.
Article de Anglais | WPRIM | ID: wpr-108745

RÉSUMÉ

BACKGROUND/AIMS: Diastolic dysfunction occurs frequently in patients with chronic kidney disease (CKD) and is associated with heart failure (HF) or mortality. We investigated whether the ratio of early diastolic mitral inflow velocity to early diastolic mitral annulus velocity (E/e' ratio), estimated using tissue Doppler imaging, has prognostic value for cardiovascular morbidity and all-cause mortality in patients with CKD. METHODS: For 186 patients with CKD of stages III to V, we obtained echocardiograms with tissue Doppler imaging. A 5-year follow-up of 136 patients was performed based on hospital records and telephone interviews. The enrolled patients (79 males and 57 females) were categorized into the following CKD subgroups: stage III (n = 25); stage IV (n = 22); and stage V (n = 89). RESULTS: The average follow-up period was 30.45 months and the mean age of the patients was 61.13 years. The mortality rate after 5 years was 60.0%. The causes of death were: sepsis, 21.9%; HF, 16.2%; and sudden death, 15.2%. Age (p = 0.000), increased C-reactive protein level (p = 0.018), and increased E/e' ratio (p = 0.048) were found to correlate with mortality. Age (p = 0.000), decreased ejection fraction (p = 0.003), and increased E/e' ratio (p = 0.045) correlated with cardiovascular event. CONCLUSIONS: The E/e' ratio can predict mortality and cardiovascular events in patients with CKD who have diastolic dysfunction.


Sujet(s)
Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Loi du khi-deux , Échocardiographie-doppler , Débit de filtration glomérulaire , Défaillance cardiaque diastolique/mortalité , Incidence , Estimation de Kaplan-Meier , Rein/physiopathologie , Modèles linéaires , Valve atrioventriculaire gauche/physiopathologie , Valeur prédictive des tests , Pronostic , Modèles des risques proportionnels , Courbe ROC , Insuffisance rénale chronique/diagnostic , République de Corée/épidémiologie , Appréciation des risques , Facteurs de risque , Débit systolique , Facteurs temps , Fonction ventriculaire gauche
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE